Weeks after the Trump administration released guidance saying private health insurers don’t have to pay for COVID-19 testing conducted for the purposes of workplace safety or public health surveillance, questions and controversy are still simmering about the implications of that edict.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.